N

Nanjing Vazyme Biotech Co Ltd
SSE:688105

Watchlist Manager
Nanjing Vazyme Biotech Co Ltd
SSE:688105
Watchlist
Price: 23.64 CNY 0.3%
Market Cap: 9.5B CNY
Have any thoughts about
Nanjing Vazyme Biotech Co Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
Nanjing Vazyme Biotech Co Ltd

Wall Street analysts forecast Nanjing Vazyme Biotech Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Nanjing Vazyme Biotech Co Ltd is 25.14 CNY with a low forecast of 22.51 CNY and a high forecast of 28.35 CNY.

Lowest
Price Target
22.51 CNY
5% Downside
Average
Price Target
25.14 CNY
6% Upside
Highest
Price Target
28.35 CNY
20% Upside
Nanjing Vazyme Biotech Co Ltd Competitors:
Price Targets
688373
Shanghai MicuRx Pharmaceutical Co Ltd
26% Upside
ALKS
Alkermes Plc
17% Upside
MRKR
Marker Therapeutics Inc
323% Upside
IONS
Ionis Pharmaceuticals Inc
75% Upside
MNPR
Monopar Therapeutics Inc
8% Upside
ACHV
Achieve Life Sciences Inc
342% Upside
CNTB
Connect Biopharma Holdings Ltd
651% Upside
COV
Covalon Technologies Ltd
33% Upside

Revenue
Forecast

Revenue Estimate
Nanjing Vazyme Biotech Co Ltd

For the last 4 years the compound annual growth rate for Nanjing Vazyme Biotech Co Ltd's revenue is 48%. The projected CAGR for the next 3 years is 26%.

48%
Past Growth
26%
Estimated Growth
Estimates Accuracy
6%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Nanjing Vazyme Biotech Co Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

Net Income Estimate
Nanjing Vazyme Biotech Co Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Nanjing Vazyme Biotech Co Ltd's stock price target?
Price Target
25.14 CNY

According to Wall Street analysts, the average 1-year price target for Nanjing Vazyme Biotech Co Ltd is 25.14 CNY with a low forecast of 22.51 CNY and a high forecast of 28.35 CNY.

What is Nanjing Vazyme Biotech Co Ltd's Revenue forecast?
Projected CAGR
26%

For the last 4 years the compound annual growth rate for Nanjing Vazyme Biotech Co Ltd's revenue is 48%. The projected CAGR for the next 3 years is 26%.

Back to Top